Multiple polysaccharide–drug complex-loaded liposomes: A unique strategy in drug loading and cancer targeting

Carbohydrate Polymers

Volumn 173, Issue , 2017, Pages 57-66

  Ruttala, Hima Bindu ^a   Ramasamy, Thiruganesh ^a   Gupta, Biki ^a   Choi, Han Gon ^b   Yong, Chul Soon ^a   Kim, Jong Oh ^a  

^a Yeungnam University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Cisplatin; Dextran sulfate; Doxorubicin; Liposome; Sodium alginate; Transferrin

Indexed keywords

CELL DEATH; CHELATION; CONJUGATED POLYMERS; CONTROLLED DRUG DELIVERY; DEXTRAN; DISEASES; LIPOSOMES; MOLAR RATIO; PLATINUM COMPOUNDS; SODIUM ALGINATE; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

BREAST CANCER CELLS; CIS-PLATIN; CONJUGATED LIPOSOMES; DEXTRAN SULFATES; DOXORUBICIN; TARGETED NANOPARTICLE; THERAPEUTIC EFFICACY; TRANSFERRIN;

TARGETED DRUG DELIVERY;

ALGINIC ACID; ANTINEOPLASTIC ANTIBIOTIC; BROMELAIN; CISPLATIN; DOXORUBICIN; GLUCURONIC ACID; HEXURONIC ACID; LIPOSOME; NANOPARTICLE; POLYSACCHARIDE;

APOPTOSIS; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; NEOPLASM; TUMOR CELL LINE;

ALGINATES; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BROMELAINS; CELL LINE, TUMOR; CISPLATIN; DOXORUBICIN; DRUG DELIVERY SYSTEMS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; LIPOSOMES; NANOPARTICLES; NEOPLASMS; POLYSACCHARIDES;

EID: 85019974790     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2017.05.062     Document Type: Article

References (38)

1. Baba, M., Pauwels, R., Balzarini, J., Arnout, J., Desmyter, J., Clercq, E.D., Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proceedings of the National Academy of Sciences of the United States of America 85 (1988), 6132–6136.
2. Cabral, H., Kataoka, K., Progress of drug-loaded polymeric micelles into clinical studies. Journal of Controlled Release 190 (2014), 465–476.
3. Cafaggi, S., Russo, E., Stefani, R., Leardi, R., Caviglioli, G., Parodi, B., et al. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex. Journal Control Release 121 (2007), 110–123.
4. Choi, J.Y., Ramasamy, T., Tran, T.H., Ku, S.K., Choi, H.G., Yong, C.S., et al. Systemic delivery of axitinib with nanohybrid liposomal nanoparticles inhibits hypoxic tumor growth. Journal of Material Chemistry B, 3, 2015, 408.
5. Dipetrillo, T., Milas, L., Evans, D., Akerman, P., Ng, T., Miner, T., et al. Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: A phase I study. American Journal of Clinical Oncology 29 (2009), 376–379.
6. Drayton, R.M., Catto, J.W., Molecular mechanisms of cisplatin resistance in bladder cancer. Expert Review of Anticancer Therapy 12 (2012), 271–281.
7. Gottesman, M.M., Mechanisms of cancer drug resistance. Annual Review of Medicine 53 (2002), 615–627.
8. Guo, S., Wang, Y., Miao, L., Xu, Z., Lin, C.M., Zhang, Y., et al. Lipid-coated cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy. ACS Nano 7 (2013), 9896–9904.
9. Harrington, K.J., Rowlinson-Busza, G., Syrigos, K.N., Vile, R.G., Uster, P.S., Peters, M., et al. Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model. Clinical Cancer Research 6 (2000), 4939–4949.
10. Hirai, M., Minematsu, H., Hiramatsu, Y., Kitagawa, H., Otani, T., Iwashita, S., et al. Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells. International Journal of Pharmaceutics 391 (2010), 274–283.
11. Imai, T., Fujii, K., Shiraishi, S., Otagiri, M., Alteration of pharmacokinetics and nephrotoxicity of cisplatin by alginates. Journal of Pharmaceutical Sciences 86 (1997), 244–247.
12. Kim, J.S., Liposomal drug delivery system. Journal of Pharmaceutical Investigation 46 (2016), 387–392.
13. Kim, J.O., Ramasamy, T., Yong, C.S., Nukolov, N.V., Bronich, T.K., Kabanov, A.V., Cross-linked polymeric micelles based on block ionomer complexes. Mendeleev Communications 23 (2013), 179–186.
14. Lam, W., Leung, C.H., Chan, H.L., Fong, W.F., Toxicity and DNA binding of dextran-doxorubicin conjugates in multidrug-resistant KB-V1 cells: Optimization of dextran size. Anti-Cancer Drugs 11 (2000), 377–384.
15. Li, Y.L., Zhu, L., Liu, Z., Cheng, R., Meng, F., Cui, J.H., et al. Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. Angewandte Chemie International Edition 48 (2009), 9914–9918.
16. Lee, E.S., Youn, Y.S., Albumin-based potential drugs: Focus on half-life extension and nanoparticle preparation. Journal of Pharmaceutical Investigation 46 (2016), 305–315.
17. Ramasamy, T., Ruttala, H.B., Kanu, B.G., Poudel, B.K., Choi, H.G., Yong, C.S., et al. Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review. J Control Release, 2017, 10.1016/j.jconrel.2017.04.043 May 1. pii: S0168-3659(17)30559-X.
18. Ramasamy, T., Poudal, B.K., Ruttala, H., Choi, J.Y., Hieu, T.D., Umadevi, K., et al. Cationic drug-based self-assembled polyelectrolyte complex micelles: Physicochemical, pharmacokinetic, and anticancer activity analysis. Colloids and Surfaces B: Biointerfaces 146 (2016), 152–160.
19. Ramasamy, T., Kim, J.H., Choi, J.Y., Tran, T.H., Choi, H.-G., Yong, C.S., et al. pH sensitive polyelectrolyte complex micelles for highly effective combination chemotherapy. Journal of Materials Chemistry B 2 (2014), 6324–6333.
20. Ramasamy, T., Tran, T.H., Choi, J.Y., Cho, H.K., Kim, J.H., Choi, H.G., et al. Layer-by-layer coated lipid–polymer hybrid nanoparticles designed for use in anticancer drug delivery. Carbohydrate Polymers, 102, 2014, 653.
21. Ramasamy, T., Ruttala, H., Choi, J., Tran, T., Kim, J., Ku, S., et al. Engineering of a lipid–polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecan. Chemical Communications 51 (2015), 5758–5761.
22. Ramasamy, T., Ruttala, H.B., Chitrapriya, N., Poudal, B.K., Choi, J.Y., Kim, S.T., et al. Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors. Acta Biomaterialia 48 (2017), 131–143.
23. Ramasamy, T., Haidar, Z.S., Tran, T.H., Choi, J.Y., Choi, H.G., Yong, C.S., et al. Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs. Acta Biomaterialia, 10, 2014, 5116.
24. Rubin, E.H., Hait, W.N., et al. Chemotherapeutic agents: Micro-tubule targeting agents. Kufe, D.W., Pollock, R.E., Weichselbaum, R.R., Bast, R.C.J., Gansler, T.S., Holland, J.F., (eds.) Cancer medicine, 6th ed., 2003, BC Decker Inc., Hamilton, Canada.
25. Ruttala, H.B., Ko, Y.T., Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy. Pharmaceutical Research 32 (2015), 1002–1016.
26. Ruttala, H.B., Ko, Y.T., Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy. Colloids and Surfaces B: Biointerfaces 128 (2015), 419–426.
27. Ruttala, H.B., Ramasamy, T., Poudel, B.K., Choi, Y.J., Choi, J.Y., Kim, J., et al. Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid–protein hybrid nanoparticles for synergistic combinational chemotherapy. Oncotarget 8 (2017), 14925–14940.
28. Ruttala, H.B., Ramasamy, T., Shin, B.S., Choi, H.G., Yong, C.S., Kim, J.O., Layer-by-layer assembly of hierarchical nanoarchitectures to enhance the systemic performance of nanoparticle albumin-bound paclitaxel. International Journal of Pharmaceutics 519 (2017), 11–21.
29. Sarisozen, C., Pan, J., Dutta, I., Torchilin, V.P., Polymers in the co-delivery of siRNA and anticancer drugs to treat multidrug-resistant tumors. Journal of Pharmaceutical Investigation 47 (2017), 37–49.
30. Sherman, S.E., Lippard, S.J., Structural aspects of platinum anticancer drug interactions with DNA. Chemical Reviews 87 (1987), 1153–1181.
31. Sun, Y., Zou, W., Bian, S., Huang, Y., Tan, Y., Liang, J., et al. Bioreducible PAA-g-PEG graft micelles with high doxorubicin loading for targeted antitumor effect against mouse breast carcinoma. Biomaterials 34 (2013), 6818–6828.
32. Sundaramoorthy, P., Ramasamy, T., Mishra, S.K., Jeong, K.Y., Yong, C.S., Kim, J.O., et al. Engineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cells. Acta Biomaterialia 42 (2016), 220–231.
33. Tan, M.L., Choong, P.F., Dass, C.R., Doxorubicin delivery systems based on chitosan for cancer therapy. Journal of Pharmacy and Pharmacology 61 (2009), 131–142.
34. Tran, T.H., Choi, J.Y., Ramasamy, T., Truong, D.H., Nguyen, C.N., Choi, H.G., et al. Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells. Carbohydrate Polymer, 114, 2015, 407.
35. Tran, T.H., Ramasamy, T., Truong, D.H., Shin, B.S., Choi, H.G., Yong, C.S., et al. Development of vorinostat-loaded solid lipid nanoparticles to enhance pharmacokinetics and efficacy against multidrug-resistant cancer cells. Pharmaceutical Research, 31, 2014, 1978.
36. Wong, H.L., Bendayan, R., Rauth, A.M., Xue, H.Y., Babakhanian, K., Wu, X.Y., A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer–lipid hybrid nanoparticle system. Journal of Pharmacology Experimental Therapeutics 317 (2006), 1372–1381.
37. Wood, J., Doxorubicin. Allwood, M., Stanley, A., Wright, P., (eds.) The cytotoxics handbook, 4th ed., 2002, Radcliffe Medical Press Ltd, Oxon, UK, 322–329.
38. Yao, X., Panichpisal, K., Kurtzman, N., Nugent, K., Nugent, cisplatin nephrotoxicity: A review. American Journal of Medical Sciences 334 (2007), 115–124.